Beyond Categorical Diagnosis: What the Depathologization of Homosexuality and Gender Incongruence Reveals about the Biological Foundations of Mental Illness

Abstract

For much of the twentieth century, homosexuality and cross-gender identification were classified by psychiatry as mental disorders, and the lay public largely accepted this framing. Beginning in 1973 with the removal of homosexuality from the Diagnostic and Statistical Manual of Mental Disorders (DSM), and continuing through the reconceptualization of “Gender Identity Disorder” into “Gender Dysphoria,” this consensus reversed as evidence accumulated that these are biologically influenced variations in human development rather than acquired pathologies. This essay argues that this historical reversal is not an isolated curiosity but an instructive case study for psychiatric nosology more broadly. Converging evidence from behavioral genetics, genome-wide association studies, and neurodevelopmental biology suggests that other conditions currently classified as discrete psychiatric “disorders” may likewise reflect biologically rooted variation that categorical, symptom-based diagnostic systems are poorly equipped to capture — a mismatch that may partly explain the persistent treatment-resistance seen across much of clinical psychiatry. The essay also addresses important disanalogies and limitations of this argument, since biological origin does not, by itself, dissolve distress, impairment, or the clinical need for intervention.

Keywords: psychiatric nosology, homosexuality, gender dysphoria, behavioral genetics, RDoC, precision psychiatry

Beyond Categorical Diagnosis: What the Depathologization of Homosexuality and Gender Incongruence Reveals about the Biological Foundations of Mental Illness

Introduction

The history of psychiatric classification is, in part, a history of revision. Diagnostic categories that once seemed self-evidently pathological have, on closer biological and empirical scrutiny, been reclassified, narrowed, or abandoned altogether. The clearest example is homosexuality, which the American Psychiatric Association listed as a mental disorder in the first two editions of the DSM before removing it in December 1973 after a review of the scientific evidence and years of activist pressure (Drescher, 2015). A parallel, if more gradual, shift occurred for gender-nonconforming identity: the diagnostic emphasis moved from pathologizing the identity itself (“Gender Identity Disorder”) toward describing only the distress that can accompany incongruence between assigned sex and gender identity (“Gender Dysphoria”) in the DSM-5 (American Psychiatric Association, 2022). In both cases, what was once treated as a disease to be corrected is now understood, in substantial part, as a biologically influenced variation to be accommodated.

This essay argues that these two reclassifications are best understood not as isolated exceptions but as an instructive precedent. If two conditions once assumed to be purely psychological in origin — and treatable through willpower, punishment, or persuasion — turned out to have substantial genetic and neurodevelopmental underpinnings, this raises a legitimate scientific question about how many other conditions currently bounded by DSM criteria are similarly rooted in biology that the categorical diagnostic system was never designed to represent. This mismatch, it will be argued, offers one explanation for why many psychiatric conditions remain difficult to treat effectively using approaches built around symptom clusters rather than underlying mechanisms.

The Historical Reclassification of Homosexuality and Gender Identity

The 1973 declassification of homosexuality followed a re-examination of what should count as a mental disorder in the first place. The American Psychiatric Association’s Nomenclature Committee, led by psychiatrist Robert Spitzer, concluded that a diagnosis required either regular subjective distress or impaired social functioning, and that homosexuality per se met neither criterion for most of the individuals who experienced it (Drescher, 2015). The decision was subsequently affirmed by a majority of the APA’s voting membership and endorsed by other major mental health organizations. Critically, the shift was driven by a convergence of empirical review and sustained advocacy rather than by a single biological discovery; the emerging consensus reframed homosexuality as a normal variant of human sexuality rather than as a pathology requiring cure.

A structurally similar shift, unfolding over subsequent decades, has occurred for gender identity. Diagnostic manuals moved from framing cross-gender identification itself as the disorder toward locating the clinical concern in the dysphoria — the distress — that can arise from incongruence, often compounded by social stigma and discrimination, rather than in the identity itself (American Psychiatric Association, 2022). In both cases, the diagnostic system evolved to distinguish an underlying trait from the suffering that can be caused by a hostile social environment or by attempts to suppress the trait — a distinction with direct relevance to the argument developed below.

Converging Genetic and Neurodevelopmental Evidence

The move away from pathologizing frameworks has been reinforced, though not single-handedly caused, by a growing body of biological evidence. Twin and family studies have long suggested a heritable component to sexual orientation, and this was substantiated at the molecular level by a genome-wide association study of nearly half a million participants, which identified five genetic loci significantly associated with same-sex sexual behavior and estimated that common genetic variants account for roughly 8% to 25% of the variation in this trait (Ganna et al., 2019). An earlier genome-wide study of male sexual orientation similarly implicated specific chromosomal regions (Sanders et al., 2017). Importantly, these studies also demonstrate that the trait is highly polygenic, with no single “gay gene,” and that genetic variants alone cannot meaningfully predict an individual’s orientation — a nuance that tempers, without negating, the case for a substantial biological contribution.

Evidence for gender identity follows a similar pattern. A twin study of children and adolescents estimated the heritability of gender identity disorder at roughly 62%, with the remaining variance attributed to non-shared environmental factors (Coolidge et al., 2002). A review of case reports on twins found that nearly 40% of monozygotic (identical) twin pairs were concordant for gender identity disorder, compared with none of the same-sex dizygotic pairs examined, a pattern consistent with a genetic contribution (Heylens et al., 2012). At the molecular level, variation in genes involved in sex-hormone signaling has been associated with gender dysphoria (Foreman et al., 2019), and earlier postmortem neuroanatomical work identified sex-atypical differences in a hypothalamic nucleus associated with transsexuality, pointing to differences that likely arise during early neurodevelopment (Zhou et al., 1995). Taken together, this literature does not establish simple genetic determinism — later population-based twin research has produced more mixed concordance estimates — but it does establish that these traits are, to a meaningful and replicable degree, rooted in biological development rather than in choice, upbringing, or moral failing, which is precisely the finding that undercut their earlier classification as curable psychopathology.

From Categorical Diagnosis to Dimensional Biology: A Broader Pattern

The significance of this history extends beyond sexuality and gender. Psychiatry’s own research establishment has begun to acknowledge that the DSM’s categorical, symptom-based architecture may not correspond well to the underlying biology of many conditions it classifies. In 2010, the U.S. National Institute of Mental Health introduced the Research Domain Criteria (RDoC) framework explicitly to reorient research away from DSM diagnostic categories and toward dimensional constructs — spanning genes, neural circuits, physiology, and behavior — that cut across traditional diagnostic boundaries (Insel et al., 2010). The RDoC initiative was motivated by the recognition that genetic and neurobiological findings routinely fail to respect DSM category boundaries, making a purely symptom-based nosology scientifically limiting.

Large-scale psychiatric genomics has borne this out directly. A genome-wide analysis by the Psychiatric Genomics Consortium found shared genetic risk loci across five major disorders — autism spectrum disorder, attention-deficit/hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia — indicating that genetic risk for psychiatric illness does not map neatly onto current diagnostic categories (Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013). A subsequent, larger analysis extended this finding to eight disorders, identifying 109 genetic loci with pleiotropic effects across two or more diagnoses and revealing broader clusters of genetically related conditions that do not correspond to DSM boundaries (Lee et al., 2019). As with sexual orientation and gender identity, the genetic architecture of these conditions is highly polygenic, involves substantial overlap between what are treated clinically as distinct illnesses, and only partially aligns with how these conditions are diagnosed and treated in practice (Gandal et al., 2016).

The parallel to the homosexuality case is direct. Just as “homosexuality” was, in retrospect, a diagnostic label that grouped a biologically grounded variation under a category defined by social judgment rather than underlying mechanism, many current psychiatric diagnoses may function as provisional groupings of clinically similar presentations that arise from etiologically heterogeneous, and sometimes overlapping, biological processes. A single DSM label such as “major depressive disorder” can be reached through many different combinations of genetic loading, neurodevelopmental history, and environmental stressor — much as a wide range of developmental pathways were once collapsed into the single, now-abandoned diagnostic label once applied to sexual orientation.

Implications for Treatment Effectiveness

This mismatch between diagnostic category and biological mechanism offers a plausible, evidence-consistent explanation for a long-standing frustration in clinical psychiatry: the inconsistent and often modest effectiveness of standard treatments for conditions such as depression, anxiety disorders, and psychotic illness. If a single diagnostic label aggregates several biologically distinct subtypes, then a treatment validated on the average response across a heterogeneous trial population will predictably help some patients, do little for others, and occasionally harm a third group — not because psychiatric treatment is inherently unreliable, but because the diagnostic unit being treated is not a single biological entity. Proponents of precision psychiatry have argued explicitly that translating genetic findings into an understanding of disease mechanism, rather than continuing to treat DSM categories as biologically unitary, is a necessary step toward more effective, individually tailored intervention (Gandal et al., 2016).

Here again the history of homosexuality is instructive, though the lesson must be drawn carefully. The failure of so-called conversion therapy to change sexual orientation was not primarily a failure of therapeutic technique so much as evidence that the target of treatment — the trait itself — was not the kind of thing that maladaptive-behavior-focused intervention could alter, because it was not, in the relevant sense, a disorder of behavior at all. By extension, it is reasonable to hypothesize that at least some of the treatment resistance observed in contemporary psychiatry reflects an analogous mismatch: interventions aimed at symptom suppression within a heterogeneous diagnostic category, rather than at the specific biological mechanism operating in a given patient. This does not imply that psychiatric treatment is illegitimate or that biological causation makes intervention unnecessary; it implies that more mechanism-specific, dimensional diagnostic tools — of the kind RDoC and psychiatric genomics are working toward — may be needed before treatment can reliably match the underlying biology of a given patient’s condition.

Limitations and Counterarguments

This argument should not be overstated, and several disanalogies deserve explicit acknowledgment. First, homosexuality and gender incongruence were unusual among DSM diagnoses in that the original criterion for disorder — distress or impaired functioning — often did not apply to the trait itself, but rather to the social stigma surrounding it; this is why Spitzer’s committee found grounds for declassification in the first place (Drescher, 2015). Many other psychiatric conditions, by contrast, are defined by intrinsic and often severe distress or functional impairment — psychotic symptoms, suicidal ideation, incapacitating anxiety — that exists independent of social attitudes and would not be resolved simply by a change in diagnostic label or public acceptance. The analogy therefore applies most directly to questions of etiology and classification, not to the separate question of whether treatment or support is warranted.

Second, a demonstrated biological or genetic component does not imply that a condition is untreatable, nor that biology and treatment responsiveness are the same axis. Schizophrenia, for example, is highly heritable, yet antipsychotic medication and psychosocial intervention produce meaningful benefit for many patients despite an incomplete mechanistic understanding of the disorder. Biological origin and treatment tractability are empirically distinct questions.

Third, all of the genetic evidence reviewed here is probabilistic and polygenic rather than deterministic; gene-environment interaction, epigenetic regulation, and developmental context remain integral to outcomes in every trait discussed, including sexual orientation and gender identity themselves (Ganna et al., 2019). Framing any of these traits as “purely genetic” would overstate the evidence in the same direction that once wrongly understated it.

Finally, this argument carries a risk of misuse in either direction: it should not be read as license to dismiss the genuine clinical needs of people with impairing psychiatric conditions, nor as a claim that all human variation currently labeled as disorder is, in fact, unproblematic difference. Distinguishing genuine pathology from medicalized variation is an empirical and clinical judgment that must be made condition by condition, using converging evidence of the kind reviewed above, rather than by analogy alone.

Conclusion

The removal of homosexuality from the DSM in 1973, and the subsequent reframing of gender identity diagnoses, mark one of the clearer instances in the history of psychiatry in which a category once treated as self-evident pathology was revised in light of accumulating biological and empirical evidence. Genome-wide association studies, twin research, and neurodevelopmental findings have since substantiated the view that these are biologically influenced variations rather than acquired disorders of choice or upbringing. This history offers a scientifically grounded, if carefully bounded, lesson for psychiatric nosology more broadly: current diagnostic categories are provisional groupings built primarily around observable symptoms, and a growing body of psychiatric genomics research — including the NIMH’s RDoC initiative and large cross-disorder genetic studies — suggests that many of these categories cut across, rather than track, the underlying biological architecture of the conditions they describe. This mismatch offers one credible explanation for the persistent difficulty of achieving consistent treatment success across much of clinical psychiatry, and it points toward a future in which diagnosis and treatment are organized increasingly around biological mechanism rather than symptom description alone, while leaving fully intact the clinical obligation to relieve genuine distress and impairment wherever they are found.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787

Coolidge, F. L., Thede, L. L., & Young, S. E. (2002). The heritability of gender identity disorder in a child and adolescent twin sample. Behavior Genetics, 32(4), 251–257. https://doi.org/10.1023/A:1019724712983

Cross-Disorder Group of the Psychiatric Genomics Consortium. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. The Lancet, 381(9875), 1371–1379. https://doi.org/10.1016/S0140-6736(12)62129-1

Drescher, J. (2015). Out of DSM: Depathologizing homosexuality. Behavioral Sciences, 5(4), 565–575. https://doi.org/10.3390/bs5040565

Foreman, M., Hare, L., York, K., Balakrishnan, K., Sánchez, F. J., Harte, F., Erasmus, J., Vilain, E., & Harley, V. R. (2019). Genetic link between gender dysphoria and sex hormone signaling. The Journal of Clinical Endocrinology & Metabolism, 104(2), 390–396. https://doi.org/10.1210/jc.2018-01105

Gandal, M. J., Leppa, V., Won, H., Parikshak, N. N., & Geschwind, D. H. (2016). The road to precision psychiatry: Translating genetics into disease mechanisms. Nature Neuroscience, 19(11), 1397–1407. https://doi.org/10.1038/nn.4409

Ganna, A., Verweij, K. J. H., Nivard, M. G., Maier, R., Wedow, R., Busch, A. S., Abdellaoui, A., Guo, S., Sathirapongsasuti, J. F., 23andMe Research Team, Lichtenstein, P., Lundström, S., Långström, N., Auton, A., Harris, K. M., Beecham, G. W., Martin, E. R., Sanders, A. R., Perry, J. R. B., Neale, B. M., & Zietsch, B. P. (2019). Large-scale GWAS reveals insights into the genetic architecture of same-sex sexual behavior. Science, 365(6456), eaat7693. https://doi.org/10.1126/science.aat7693

Heylens, G., De Cuypere, G., Zucker, K. J., Schelfaut, C., Elaut, E., Vanden Bossche, H., De Baere, E., & T’Sjoen, G. (2012). Gender identity disorder in twins: A review of the case report literature. The Journal of Sexual Medicine, 9(3), 751–757. https://doi.org/10.1111/j.1743-6109.2011.02567.x

Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010). Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders. American Journal of Psychiatry, 167(7), 748–751. https://doi.org/10.1176/appi.ajp.2010.09091379

Lee, P. H., Anttila, V., Won, H., Feng, Y. A., Rosenthal, J., Zhu, Z., Tucker-Drob, E. M., Nivard, M. G., Grotzinger, A. D., Posthuma, D., ... Smoller, J. W. (2019). Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell, 179(7), 1469–1482. https://doi.org/10.1016/j.cell.2019.11.020

Sanders, A. R., Beecham, G. W., Guo, S., Dawood, K., Rieger, G., Badner, J. A., Gershon, E. S., Krishnappa, R. S., Kolundzija, A. B., Duan, J., Shi, J., Levinson, D. F., Mowry, B. J., Olincy, A., Amin, F., Cloninger, C. R., Svrakic, D. M., Silverman, J. M., Buccola, N. G., Byerley, W. F., Black, D. W., Freedman, R., Gejman, P. V., Bailey, J. M., & Martin, E. R. (2017). Genome-wide association study of male sexual orientation. Scientific Reports, 7(1), Article 16950. https://doi.org/10.1038/s41598-017-15736-4

Zhou, J.-N., Hofman, M. A., Gooren, L. J. G., & Swaab, D. F. (1995). A sex difference in the human brain and its relation to transsexuality. Nature, 378(6552), 68–70. https://doi.org/10.1038/378068a0